FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
Cancer immunotherapy has been extensively investigated in lymphoma over the last three decades. This new treatment modality is now established as a way to manage and maintain several stages and subtypes of lymphoma. The establishment of this novel therapy has necessitated the development of new imag...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/15/4/1063 |
| _version_ | 1797621929592487936 |
|---|---|
| author | Akram Al-Ibraheem Ahmed Saad Abdlkadir Malik E. Juweid Kamal Al-Rabi Mohammad Ma’koseh Hikmat Abdel-Razeq Asem Mansour |
| author_facet | Akram Al-Ibraheem Ahmed Saad Abdlkadir Malik E. Juweid Kamal Al-Rabi Mohammad Ma’koseh Hikmat Abdel-Razeq Asem Mansour |
| author_sort | Akram Al-Ibraheem |
| collection | DOAJ |
| description | Cancer immunotherapy has been extensively investigated in lymphoma over the last three decades. This new treatment modality is now established as a way to manage and maintain several stages and subtypes of lymphoma. The establishment of this novel therapy has necessitated the development of new imaging response criteria to evaluate and follow up with cancer patients. Several FDG PET/CT-based response criteria have emerged to address and encompass the various most commonly observed response patterns. Many of the proposed response criteria are currently being used to evaluate and predict responses. The purpose of this review is to address the efficacy and side effects of cancer immunotherapy and to correlate this with the proposed criteria and relevant patterns of FDG PET/CT in lymphoma immunotherapy as applicable. The latest updates and future prospects in lymphoma immunotherapy, as well as PET/CT potentials, will be discussed. |
| first_indexed | 2024-03-11T09:03:01Z |
| format | Article |
| id | doaj.art-6d4df7c16cd84cc8bbc9c8582bd9ccdf |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-11T09:03:01Z |
| publishDate | 2023-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-6d4df7c16cd84cc8bbc9c8582bd9ccdf2023-11-16T19:35:36ZengMDPI AGCancers2072-66942023-02-01154106310.3390/cancers15041063FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future ProspectsAkram Al-Ibraheem0Ahmed Saad Abdlkadir1Malik E. Juweid2Kamal Al-Rabi3Mohammad Ma’koseh4Hikmat Abdel-Razeq5Asem Mansour6Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center, Al-Jubeiha, Amman 11941, JordanDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center, Al-Jubeiha, Amman 11941, JordanDepartment of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University of Jordan, Amman 11942, JordanDepartment of Medical Oncology, King Hussein Cancer Center, Amman 11941, JordanDepartment of Medical Oncology, King Hussein Cancer Center, Amman 11941, JordanDepartment of Internal Medicine, King Hussein Cancer Center, Amman 11941, JordanDepartment of Diagnostic Radiology, King Hussein Cancer Center, Amman 11941, JordanCancer immunotherapy has been extensively investigated in lymphoma over the last three decades. This new treatment modality is now established as a way to manage and maintain several stages and subtypes of lymphoma. The establishment of this novel therapy has necessitated the development of new imaging response criteria to evaluate and follow up with cancer patients. Several FDG PET/CT-based response criteria have emerged to address and encompass the various most commonly observed response patterns. Many of the proposed response criteria are currently being used to evaluate and predict responses. The purpose of this review is to address the efficacy and side effects of cancer immunotherapy and to correlate this with the proposed criteria and relevant patterns of FDG PET/CT in lymphoma immunotherapy as applicable. The latest updates and future prospects in lymphoma immunotherapy, as well as PET/CT potentials, will be discussed.https://www.mdpi.com/2072-6694/15/4/1063immunotherapy 1immunotherapy in lymphoma 2FDG PET/CT 3metabolic PET parameters 4lymphoma immunotherapy response criteria 5immuno-PET 6 |
| spellingShingle | Akram Al-Ibraheem Ahmed Saad Abdlkadir Malik E. Juweid Kamal Al-Rabi Mohammad Ma’koseh Hikmat Abdel-Razeq Asem Mansour FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects Cancers immunotherapy 1 immunotherapy in lymphoma 2 FDG PET/CT 3 metabolic PET parameters 4 lymphoma immunotherapy response criteria 5 immuno-PET 6 |
| title | FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects |
| title_full | FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects |
| title_fullStr | FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects |
| title_full_unstemmed | FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects |
| title_short | FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects |
| title_sort | fdg pet ct in the monitoring of lymphoma immunotherapy response current status and future prospects |
| topic | immunotherapy 1 immunotherapy in lymphoma 2 FDG PET/CT 3 metabolic PET parameters 4 lymphoma immunotherapy response criteria 5 immuno-PET 6 |
| url | https://www.mdpi.com/2072-6694/15/4/1063 |
| work_keys_str_mv | AT akramalibraheem fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT ahmedsaadabdlkadir fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT malikejuweid fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT kamalalrabi fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT mohammadmakoseh fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT hikmatabdelrazeq fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects AT asemmansour fdgpetctinthemonitoringoflymphomaimmunotherapyresponsecurrentstatusandfutureprospects |